Repare Therapeutics Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Repare Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2021 to Q2 2024.
  • Repare Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$34.8M, a 191% decline year-over-year.
  • Repare Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$68.5M, a 2122% decline year-over-year.
  • Repare Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$93.8M, a 223% decline from 2022.
  • Repare Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29M, a 72.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$68.5M -$34.8M -$22.8M -191% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$45.7M $13.2M +$48.1M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$93.8M -$28M +$3.63M +11.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$97.4M -$18.9M -$94.3M -125% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$3.08M -$11.9M +$26.1M +68.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$29.2M -$34.9M -$184K -0.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$29M -$31.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $75.5M +$106M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$38.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$34.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$30.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.